|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-4-23
|
|
pubmed:abstractText |
The Preoperative Chemotherapy in Primary Operable Breast Cancer (POCOB) study was designed to compare preoperative with postoperative chemotherapy in patients with early breast cancer concerning breast conserving therapy (BCT) procedures, disease free survival (DFS) and overall survival (OS).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1573-7217
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
101-13
|
|
pubmed:meshHeading |
pubmed-meshheading:18484198-Adult,
pubmed-meshheading:18484198-Antineoplastic Agents,
pubmed-meshheading:18484198-Breast Neoplasms,
pubmed-meshheading:18484198-Disease-Free Survival,
pubmed-meshheading:18484198-Female,
pubmed-meshheading:18484198-Follow-Up Studies,
pubmed-meshheading:18484198-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18484198-Humans,
pubmed-meshheading:18484198-Middle Aged,
pubmed-meshheading:18484198-Neoplasm Recurrence, Local,
pubmed-meshheading:18484198-Prognosis,
pubmed-meshheading:18484198-Recurrence,
pubmed-meshheading:18484198-Time Factors,
pubmed-meshheading:18484198-Treatment Outcome,
pubmed-meshheading:18484198-Tumor Markers, Biological
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
|
|
pubmed:affiliation |
Department of Surgery, K6-R, Leiden University Medical Centre, Leiden, the Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
